knowledge -WSS

knowledge

author：focus 2025-10-01 00:07:05 - browse：42

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Shionogi licenses Pompe disease therapy from Maze Therapeutics

WSS

Experts study whether long Covid risk adds up with each reinfection

What will Novo Nordisk's VC do with its influx of cash?

The biotech scorecard for Q4: 16 stock

Experts study whether long Covid risk adds up with each reinfection

Study points to new risk in gene therapy death of Terry Horgan

Study: Adult vaccinations pay for themselves in societal benefits

explore

knowledge

focus

Walensky prepares to leave CDC — and Congress — behind

How to improve immunocompromised access to mAb treatments

At least 13 dead in Texas as scorching temps continue

Researchers on aging grapple with how to calculate biological age

Hollywood unions extend contract negotiations for actors

Google says AlphaFold 3 can map a vast universe of biomolecules

Walensky prepares to leave CDC — and Congress — behind

How to improve immunocompromised access to mAb treatments

Medicare details structure of new drug price negotiation program

Experts study whether long Covid risk adds up with each reinfection

knowledge

Congress extends some pandemic preparedness programs

After gene therapy, two congenitally deaf children hear for the first time

Researchers on aging grapple with how to calculate biological age

Flu, Covid vaccination rates decline, new survey data show

RSV injection headlines need to be accurate for good uptake

H5N1 communication has been strictly for the birds

entertainment

Wikipedia

knowledge

entertainment